Table 1. Characteristics Of Included Studies.
Patient characteristics | ||||||||||||
IVIG | Corticosteroids (starting regimen) | |||||||||||
Study name | Total (n) | Standard therapy | Standard therapy + corticosteroids | Male (%) | Age (years) | Maximum days before enrollment | Aspirin regimen (mg/kg) | Dose (mg/kg) | Number of doses | Preparation | Dosage (mg/kg) | Frequency (times/day) |
Inoue 2006 | 178 | 88 | 90 | 57.3 | 4.5 | 9 | 30 | 1 | 2 | pednisolone | 2 | 3 |
Newburger 2007 | 199 | 98 | 101 | 62 | 2.9 | 10 | 80–100 | 2 | 1 | IV methylprednisolone | 30 | 1 |
Okada 2003 | 32 | 18 | 14 | 56.25 | 2.75 | 9 | 30 | 1 | 2 | pednisolone | 2 | 3 |
Sundel 2003 | 39 | 21 | 18 | 69 | - | 10 | 20–25 | 2 | 1 | IV methylprednisolone | 30 | 1 |